Adenosine derivatives having a2a receptor activity

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 19/167 (2006.01) A61K 31/7076 (2006.01) A61P 9/00 (2006.01) C07D 473/00 (2006.01) C07D 473/16 (2006.01)

Patent

CA 2598865

Compounds of (I), or stereoisomers or pharmaceutically acceptable salts thereof, where W, R1, R2, R3 and R4 have the meanings as indicated in the specification, are useful for treating conditions mediated by activation of the adenosine A2A receptor, especially inflammatory or obstructive airways diseases. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.

La présente invention concerne des composés de (1) stéréoisomères ou des sels pharmaceutiquement acceptables de ceux-ci, où W, R1, R2, R3 et R4 désignent des éléments définis dans la description de la présente demande. Ces composés sont utiles pour le traitement de troubles induits par l~activation du récepteur A2A de l~adénosine, en particulier des maladies inflammatoires et obstructives des voies respiratoires. L~invention concerne également des compositions pharmaceutiques contenant les composés de l~invention, ainsi que des procédés destinés à la préparation de ces composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Adenosine derivatives having a2a receptor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adenosine derivatives having a2a receptor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine derivatives having a2a receptor activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1354839

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.